The limitation of our current study is that all the experiments were conducted at the in vitro level, therefore, the therapeutic evaluations and superior antitumor effect of GEM-HSA-NP on MDR1- and MRP1-overexpressing pancreatic cancers needs to be further elucidated in vivo in our future work. The gene discussed is ABCC1; the disease is pancreatic neoplasm.